Outcome of the Precision Medicine Alliance Scotland Funding Call
18th January 2022
On Thursday 27 May 2021, the Chief Scientist Office (CSO) launched the Precision Medicine Alliance Scotland funding call
Applications were invited for Scottish-led research to support NHS Boards in the development and delivery of Precision Medicine based approaches to tackle health conditions of major importance in Scotland, including diseases that disproportionately impact those at risk of socioeconomic disadvantage.
The response from the research community was outstanding, with 10 applications submitted by the 11 August 2021 deadline.
CSO convened an international expert panel to review the applications, chaired by Professor Keith Channon, Field Marshal Earl Alexander Professor of Cardiovascular Medicine at the University of Oxford. Following application triage and interviews, 4 projects were recommended for funding.
NHS Lothian has been awarded £6.94 million to deliver the following projects:
- Precision-MS: Integrating Precision Metrics of Brain Health into Early Treatment of Multiple Sclerosis
- Lead Investigator: Professor David Hunt
- Centre for Precision Cell Therapy for the Liver
- Lead Investigator: Professor Stuart Forbes
- Time Critical Precision Medicine for Acute Critical Illness Using Treatable Trait Principles: Data Enabled Adaptive Platform Trial with Embedded Biological Characterisation
- Lead Investigator: Professor Manu Shankar-Hari
NHS Tayside has been awarded £2.81 million to deliver the following project:
- The iDiabetes Platform: Enhanced Phenotyping of patients with diabetes for Precision Diagnosis, Prognosis and Treatment
- Lead Investigator: Professor Ewan Pearson
CSO would like to thank all of those who submitted applications, and the chair, members and lay members of the review panel.